Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,276 | 64 | 97.3% |
| Education | $34.92 | 2 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $303.40 | 14 | $0 (2024) |
| Lilly USA, LLC | $123.49 | 7 | $0 (2021) |
| Indivior Inc. | $116.75 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $114.50 | 6 | $0 (2024) |
| PFIZER INC. | $106.71 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $54.83 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $52.79 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $49.12 | 3 | $0 (2021) |
| Alkermes, Inc. | $44.41 | 3 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $44.19 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $363.76 | 16 | PFIZER INC. ($106.71) |
| 2023 | $79.32 | 4 | Gilead Sciences, Inc. ($49.76) |
| 2022 | $164.71 | 8 | Gilead Sciences, Inc. ($62.51) |
| 2021 | $307.03 | 16 | Gilead Sciences, Inc. ($134.69) |
| 2020 | $267.93 | 15 | Lilly USA, LLC ($105.32) |
| 2019 | $127.75 | 7 | Indivior Inc. ($41.33) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: NEUROLOGY | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardio-renal | ||||||
| 09/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Oncology | ||||||
| 07/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: VACCINES | ||||||
| 06/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/17/2024 | PFIZER INC. | COMIRNATY (Biological) | Food and Beverage | In-kind items and services | $47.48 | General |
| Category: VACCINES | ||||||
| 06/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.11 | General |
| 06/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: PAIN | ||||||
| 04/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.65 | General |
| 03/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/29/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINES | ||||||
| 02/09/2024 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 02/07/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: OUD | ||||||
| 01/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: VACCINES | ||||||
| 09/25/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: VIROLOGY | ||||||
| 09/18/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 02/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.94 | General |
| 02/02/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: OUD | ||||||
| 10/04/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.70 | General |
| 07/07/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Respiratory | ||||||
| 03/09/2022 | Pear Therapeutics (US), Inc. | reSET-O (Device) | Food and Beverage | Cash or cash equivalent | $27.81 | General |
| Category: Prescription Digital Therapeutics | ||||||
| 03/09/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Respiratory | ||||||
| 02/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.70 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 305 | 650 | $174,245 | $57,751 |
| 2022 | 14 | 505 | 1,026 | $265,155 | $79,277 |
| 2021 | 12 | 590 | 1,111 | $326,132 | $93,438 |
| 2020 | 13 | 774 | 1,454 | $432,219 | $113,266 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 284 | $56,800 | $20,967 | 36.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 105 | 182 | $70,980 | $18,337 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 82 | $18,930 | $8,442 | 44.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 21 | $6,825 | $5,040 | 73.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $8,580 | $1,821 | 21.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 22 | $5,720 | $1,474 | 25.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $5,400 | $1,312 | 24.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 14 | 14 | $770.00 | $306.60 | 39.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 12 | $240.00 | $52.44 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 388 | $77,600 | $28,525 | 36.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 151 | 272 | $106,080 | $23,602 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 82 | $18,860 | $8,448 | 44.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 104 | $27,040 | $6,335 | 23.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 50 | 50 | $20,000 | $4,452 | 22.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $4,300 | $3,211 | 74.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,300 | $1,630 | 49.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,850 | $1,264 | 32.8% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 15 | 16 | $1,080 | $652.30 | 60.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 19 | 19 | $760.00 | $398.47 | 52.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $570.00 | $370.69 | 65.0% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $495.00 | $167.09 | 33.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $900.00 | $154.64 | 17.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 16 | 16 | $320.00 | $67.60 | 21.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 220 | 396 | $154,440 | $34,711 | 22.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 353 | $70,600 | $26,078 | 36.9% |
About Dr. Hamid Danesh, MD
Dr. Hamid Danesh, MD is a Internal Medicine healthcare provider based in Lowell, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811961196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hamid Danesh, MD has received a total of $1,311 in payments from pharmaceutical and medical device companies, with $363.76 received in 2024. These payments were reported across 66 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,276).
As a Medicare-enrolled provider, Danesh has provided services to 2,174 Medicare beneficiaries, totaling 4,241 services with total Medicare billing of $343,733. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lowell, MA
- Active Since 02/14/2006
- Last Updated 08/22/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811961196
Products in Payments
- TRULICITY (Drug) $123.49
- SUBLOCADE (Drug) $116.75
- TRELEGY ELLIPTA (Drug) $75.12
- BREZTRI (Drug) $52.79
- AJOVY (Biological) $49.12
- COMIRNATY (Biological) $47.48
- Kerendia (Drug) $44.19
- PREVNAR 20 (Biological) $41.29
- Ozempic (Drug) $39.47
- TRADJENTA (Drug) $36.32
- XIFAXAN (Drug) $32.21
- Vivitrol (Drug) $31.01
- VOQUEZNA (Drug) $29.83
- INSPIRE (Device) $28.80
- reSET-O (Device) $27.81
- SHINGRIX (Biological) $24.66
- Cologuard Collection Kit (Device) $22.66
- Mavyret (Drug) $21.57
- ENTRESTO (Drug) $20.96
- Kcentra (Biological) $20.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lowell
Winnie Szeto, Md, MD
Internal Medicine — Payments: $20,659
Dragan Petakov, Md, MD
Internal Medicine — Payments: $14,487
Sachin Patel, M.d, M.D
Internal Medicine — Payments: $7,643
Dr. Francis Magro, M.d, M.D
Internal Medicine — Payments: $7,395
Dr. Philip Kotsios, M.d, M.D
Internal Medicine — Payments: $4,725
Anil Jha, M.d, M.D
Internal Medicine — Payments: $4,478